Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 5000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 1000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - white shrimp -

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - secale cereale -

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - 38442 - unclassified - the transfer cannula provided with the procedure pack is for the transfer of solvent (water for injection) to the vial containing lyophilised alteplase for reconstitution of the final product for injection. the final product for injection is for use in the registered indications.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - 38442 - unclassified - the transfer cannula provided with the procedure pack is for the transfer of solvent (water for injection) to the vial containing lyophilised alteplase for reconstitution of the final product for injection. the final product for injection is for use in the registered indications.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - glyceryl trinitrate 0.2%{relative} (as 4%w/w glyceryl trintrate 5%w/w solution);   - rectal ointment - 0.2% w/w - active: glyceryl trinitrate 0.2%{relative} (as 4%w/w glyceryl trintrate 5%w/w solution)   excipient: ethanol lanolin liquid paraffin yellow soft paraffin - rectogesic rectal ointment is indicated for the treatment of anal fissure and relief of the symptoms associated with anal fissure. may assist in relief of pain and discomfort associated with haemorrhoids and haemorrhoidectomy.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.